These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 38473414)

  • 1. Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention.
    Muranaka H; Akinsola R; Billet S; Pandol SJ; Hendifar AE; Bhowmick NA; Gong J
    Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle.
    Wang B; Pei J; Xu S; Liu J; Yu J
    J Exp Clin Cancer Res; 2024 Mar; 43(1):74. PubMed ID: 38459595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaminolysis: A Hallmark of Cancer Metabolism.
    Yang L; Venneti S; Nagrath D
    Annu Rev Biomed Eng; 2017 Jun; 19():163-194. PubMed ID: 28301735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamine metabolism in breast cancer and possible therapeutic targets.
    Li S; Zeng H; Fan J; Wang F; Xu C; Li Y; Tu J; Nephew KP; Long X
    Biochem Pharmacol; 2023 Apr; 210():115464. PubMed ID: 36849062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirpiglenastat (DRP-104) Induces Antitumor Efficacy through Direct, Broad Antagonism of Glutamine Metabolism and Stimulation of the Innate and Adaptive Immune Systems.
    Yokoyama Y; Estok TM; Wild R
    Mol Cancer Ther; 2022 Oct; 21(10):1561-1572. PubMed ID: 35930753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis.
    Sharma S; Agnihotri N; Kumar S
    Biochem Pharmacol; 2022 Apr; 198():114943. PubMed ID: 35131295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus.
    Zhu Y; Li T; Ramos da Silva S; Lee JJ; Lu C; Eoh H; Jung JU; Gao SJ
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation.
    Cruzat V; Macedo Rogero M; Noel Keane K; Curi R; Newsholme P
    Nutrients; 2018 Oct; 10(11):. PubMed ID: 30360490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential glutamine metabolism in the tumor microenvironment - studies in diversity and heterogeneity: A mini-review.
    Claiborne MD; Leone R
    Front Oncol; 2022; 12():1011191. PubMed ID: 36203456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia.
    Xiao Y; Hu B; Guo Y; Zhang D; Zhao Y; Chen Y; Li N; Yu L
    Curr Treat Options Oncol; 2023 Aug; 24(8):1021-1035. PubMed ID: 37249801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming of glutamine involved in tumorigenesis, multidrug resistance and tumor immunity.
    Xiao-Yan W; Xiao-Xia Y; Peng-Fei S; Zong-Xue Z; Xiu-Li G
    Eur J Pharmacol; 2023 Feb; 940():175323. PubMed ID: 36535492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamine Metabolism in Cancer.
    Li T; Copeland C; Le A
    Adv Exp Med Biol; 2021; 1311():17-38. PubMed ID: 34014532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular therapeutic strategies targeting pancreatic cancer induced cachexia.
    Yakovenko A; Cameron M; Trevino JG
    World J Gastrointest Surg; 2018 Dec; 10(9):95-106. PubMed ID: 30622678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Cellular Adaptive Responses to Glutaminolysis Perturbation for Cancer Therapy.
    Kim M; Hwang S; Jeong SM
    Mol Cells; 2024 Jul; ():100096. PubMed ID: 39038517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine supplementation in catabolic patients.
    Sacks GS
    Ann Pharmacother; 1999 Mar; 33(3):348-54. PubMed ID: 10200861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific amino acids in the critically ill patient--exogenous glutamine/arginine: a common denominator?
    Vermeulen MA; van de Poll MC; Ligthart-Melis GC; Dejong CH; van den Tol MP; Boelens PG; van Leeuwen PA
    Crit Care Med; 2007 Sep; 35(9 Suppl):S568-76. PubMed ID: 17713411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamine supplementation in cancer patients.
    Yoshida S; Kaibara A; Ishibashi N; Shirouzu K
    Nutrition; 2001 Sep; 17(9):766-8. PubMed ID: 11527675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Leukemia Treatment: The Role of Combined Therapies Based on Amino Acid Starvation.
    Chen C; Zhang J
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role and therapeutic targeting of glutamine metabolism in non‑small cell lung cancer (Review).
    Zhou L; Zhang Q; Zhu Q; Zhan Y; Li Y; Huang X
    Oncol Lett; 2023 Apr; 25(4):159. PubMed ID: 36936031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.